MedPacto, Inc.

₩3,340As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:235980Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (22.33%)
Div yield —
ROE (30.76%)
Biotechnology
Beta (5Y) 0.11
PE TTM —
TSR TTM (23.04%)
Mkt cap ₩114.5B
ROIC (20.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,238
(3.07%)
(52.93%)
Sell 2|7|11|6|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
77.80
86.53
87.74
95.78
7.53%
17.47%
10.12%
19.03%
Revenue₩B
5.798
5.787
5.972
6.141
(1.78%)
(0.09%)
6.07%
9.29%
Peers (US$84.40M)
Cap (US$)
PE
92.95M
—
84.53M
—
Capital
TTM
5Y
10Y
Leveragex
3.213
(0.969)
(0.697)
EBIT/Intx
1.361
0.168
0.159
Own earn%
348.93
300.63
270.76
Sh yield%
42.81
38.79
36.74
Owners
Insiders/Inst%
2.86
22.75
Short interest%
1.42
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
26–30
$1 testx
0.0
Incr. ROIC%
6